Vishal Sikri
President at Inivata Ltd.
Net worth: 2 M $ as of 31/05/2024
Vishal Sikri active positions
| Companies | Position | Start | End |
|---|---|---|---|
Inivata Ltd.
 Inivata Ltd. Packaged SoftwareTechnology Services Inivata Ltd. develops new clinical applications for ctDNA analysis. It is a clinical cancer genomics company harnessing the potential of circulating tumour DNA (ctDNA) analysis to improve cancer testing and treatment. The firm is focused on developing clinical applications of ctDNA through collaborations with clinical oncologists at prominent academic institutions, leading community treatment centres and innovative biopharmaceutical companies. The company was founded by James Brenton, Tim Forshew, Rosenfeld Nitzan and Davina Gale on July 23, 2014 and is headquartered in Cambridge, the United Kingdom. | President | 23/05/2022 | - |
Career history of Vishal Sikri
Former positions of Vishal Sikri
| Companies | Position | Start | End |
|---|---|---|---|
| NEOGENOMICS, INC. | Corporate Officer/Principal | 23/05/2022 | 15/04/2024 |
Training of Vishal Sikri
| Beloit College | Undergraduate Degree |
| University of Wisconsin | Graduate Degree |
| Loyola University of Chicago | Masters Business Admin |
Statistics
International
| United States | 5 |
| United Kingdom | 2 |
Operational
| President | 1 |
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Consumer Services | 4 |
| Technology Services | 2 |
| Health Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| NEOGENOMICS, INC. | Health Services |
| Private companies | 1 |
|---|---|
Inivata Ltd.
Inivata Ltd. Packaged SoftwareTechnology Services Inivata Ltd. develops new clinical applications for ctDNA analysis. It is a clinical cancer genomics company harnessing the potential of circulating tumour DNA (ctDNA) analysis to improve cancer testing and treatment. The firm is focused on developing clinical applications of ctDNA through collaborations with clinical oncologists at prominent academic institutions, leading community treatment centres and innovative biopharmaceutical companies. The company was founded by James Brenton, Tim Forshew, Rosenfeld Nitzan and Davina Gale on July 23, 2014 and is headquartered in Cambridge, the United Kingdom. | Technology Services |
- Stock Market
- Insiders
- Vishal Sikri
- Experience
